1. Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial. (November 2020) Authors: Johnsen, Erik; Kroken, Rune A; Løberg, Else-Marie; Rettenbacher, Maria; Joa, Inge; Larsen, Tor Ketil; Reitan, Solveig Klæbo; Walla, Berit; Alisauskiene, Renata; Anda, Liss Gøril; Bartz-Johannessen, Christoffer; Berle, Jan Øystein; Bjarke, Jill; Fathian, Farivar; Hugdahl, Kenneth; Kjelby, Eirik; S... Journal: Lancet Issue: Volume 7:Number 11(2020) Page Start: 945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST). (March 2023) Authors: Winter-van Rossum, Inge; Weiser, Mark; Galderisi, Silvana; Leucht, Stefan; Bitter, Istvan; Glenthøj, Birte; Hasan, Alkomiet; Luykx, Jurjen; Kupchik, Marina; Psota, Georg; Rocca, Paola; Stefanis, Nikos; Teitelbaum, Alexander; Bar Haim, Mor; Leucht, Claudia; Kemmler, Georg; Schurr, Timo; Davidson, ... Journal: Lancet Issue: Volume 10:Number 3(2023) Page Start: 197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗